Transcarent vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Transcarent is an AI-powered health and care platform for employers that connects employees to transparent, high-value care and eliminates unnecessary healthcare spending.
About
Transcarent is a health and care company founded in 2020 by Glen Tullman, the founder of Livongo, that has raised over $450M to build an AI-powered health navigation platform for self-insured employers. The platform serves as a concierge health experience for employees, using AI to match members with high-quality providers, guide them to appropriate care settings, and help them avoid costly unnecessary procedures. Transcarent's WayFinding AI model draws on clinical data and quality metrics to direct employees to top-tier providers for specific conditions and procedures. The company has acquired 98point6, a virtual primary care platform, to integrate physician-delivered AI-powered primary care into its offering. Transcarent serves large self-insured employers that bear the full cost of employee healthcare and are motivated to improve quality while reducing unnecessary spending. The company promises employers cost savings and employees a better experience by removing the complexity that makes navigating healthcare so difficult. As employer healthcare costs continue rising, Transcarent addresses a massive market need for intelligent navigation that connects the right patient with the right care at the right cost.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.